Drug Approval Package
-
NEXIUM for Delayed Release Oral Suspension
Company: AstraZeneca LLP
NDA: 21957
Approval Date: 10/24/2006
- Approval Letter(s) (PDF)
- Printed Labeling (PDF)
- Medical Review(s) (PDF)
- Chemistry Review(s) (PDF)
- Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
- Proprietary Name Review(s) (PDF)
- Administrative Document(s) and Correspondence (PDF)
Date created: September 4, 2008
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-